Concepedia

Paula Colón‐Bolea

PC

5

Publications

301

Citations

5

H-Index

2015

Active since

Affiliations

Instituto de Biomedicina y Biotecnología de Cantabria(Current)

Universidad de Cantabria

Consejo Superior de Investigaciones Científicas

Instituto de Salud Carlos III

Centro de Investigación Biomédica en Red de Cáncer

Paula Colón‐Bolea is an author at Instituto de Biomedicina y Biotecnología de Cantabria specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyCytoskeletonTumor BiologyCell SignalingCell PhysiologySystems BiologyRadiation OncologyTumor MicroenvironmentAutophagy

Publications per year

2015–2020

5

Publications

5

Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

Ana Herrero, Adán Pinto, Paula Colón‐Bolea et al. · Cancer Cell · 2015 · 148 citations

Cell Regulation, Receptor Tyrosine Kinase, Ras-erk Pathway Oncogenes +6

The <i><scp>USP</scp>8</i> mutational status may predict long‐term remission in patients with Cushing's disease

Adriana Albani, Luis Gustavo Perez‐Rivas, Christina Dimopoulou et al. · Clinical Endocrinology · 2018 · 76 citations

RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation

Berta Casar, Andrew P. Badrock, Iñaki Jiménez et al. · Nature Communications · 2018 · 36 citations · Full text

Defined spatiotemporal features of RAS-ERK signals dictate cell fate in MCF-7 mammary epithelial cells

Ana Herrero, Berta Casar, Paula Colón‐Bolea et al. · Molecular Biology of the Cell · 2016 · 25 citations · Full text

Cell Death, Spatiotemporal Features, Cytoskeleton +27

RAC1 induces nuclear alterations through the LINC complex to enhance melanoma invasiveness

Paula Colón‐Bolea, Rocío García‐Gómez, Sue Shackleton et al. · Molecular Biology of the Cell · 2020 · 16 citations · Full text

Cytoskeleton, Cancer Biology, Cellular Physiology +18

Rows per page

1–5 of 5